eISSN: 1994-4624 / ISSN: 1813-176x
Register
Login
International Journal of Molecular Medicine and Advance Sciences
2010, Volume 6, Issue 3 : 43-48 doi: ijmmas.2010.43.48
Research Article
Susceptibility Faecal Isolates of Commensal <I>E. coli </I>from Cattle to Fluoroquinolones and Cephalosporins
Published
June 30, 2005
Abstract

About 500 isolates of <I>Escherichia coli </I>were recovered from apparently healthy cattle and tested for their susceptibility to third generation cephalosporins and extended spectrum beta-lactamase producers were detected using the double dusk synergy test. Representative isolates were selected on the basis of their cephalosporin resistance patterns for plasmids analysis and mating experiment using <I>E. coli </I>25922 as recipient. Resistance to cefoxitin was highest as 395 (79.0%) showed resistance to the antibiotic while resistance to ceftriaxone was the lowest with 87 (17.4%) isolates. Seventy two isolates were confirmed to be extended spectrum beta-lactamase producers. Two of 13 representative isolates selected among the extended spectrum beta lactamase producers carried single plasmids while the remaining 11 isolates contain multiple plasmids ranging from 1.2-22.2 kb. The cephalosporin-resistant isolates also carried plasmids with sizes ranging from 4.32-32 kb. Twelve isolates among the extended spectrum beta-lactamase producers that carried plasmids successfully transferred the plasmids to the recipient while all the cephalosporin-resistant isolates successful transferred plasmids to the recipient strain. The use of third-generation cephalosporins in animal medicine should be regulated.

Keywords
License
Copyright (c) International Journal of Molecular Medicine and Advance Sciences
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Int. J. Mol. Med. Adv. Sci. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Recommended Articles
Predictors of Acute Coronary Syndrome Outcomes: A Multicenter Evaluation of Clinical, Biochemical, and Demographic Risk Factors
11-15
Internet of Medical Things in Healthcare Delivery: Transforming Modern Healthcare Through Connected Technologies
1-6
Healthcare Disparities and Equity in Medical Services: Challenges, Determinants, and Strategies for Achieving Equitable Healthcare
27-34
Wearable Devices for Chronic Disease Monitoring: Transforming Healthcare Through Continuous Digital Health Surveillance
22-26
International Journal of Molecular Medicine and Advance Sciences
+447480266638
+447480266638
support@ijmmas.com
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) license. Open Access Publication.
Copyright © ©International Journal of Molecular Medicine and Advance Sciences. All rights reserved.